Director/PDMR Shareholding

RNS Number : 8619D

AstraZeneca PLC

29 March 2011

 



Transaction by Persons Discharging Managerial Responsibilities

Disclosure Rule DTR 3.1.4

On 28 March 2011, the interest of the following individuals, who are all persons discharging managerial responsibilities, in AstraZeneca PLC ordinary shares, changed as detailed below.  The change in interest relates to the vesting of previously announced awards made in March 2008 under the AstraZeneca Performance Share Plan or, for Jeff Pott, the AstraZeneca Executive Performance Share Plan, whereby, following the application of performance measures specified at the time of grant, the individuals concerned have now become beneficially entitled to 125% of the shares originally awarded.  In each case, sufficient vested shares were withheld to cover certain tax obligations arising on the vesting.  The interests of Jeff Pott, Lynn Tetrault and Tony Zook are in the Company's American Depositary Shares (ADSs).  One ADS equals one ordinary share.

Name	Shares awarded	Shares vested	Shares withheld	Net shares received	Market price on vesting
Anders Ekblom	5,316	6,645	0	6,645	2874p
Jeff Pott	6,773	8,466	4,112	4,354	$46.14
David Smith	27,098	33,872	9,109	24,763	2874p
Lynn Tetrault	50,950	63,687	26,240	37,447	$46.14
Tony Zook	73,411	91,763	37,669	54,094	$46.14

On 29 March 2011, David Smith sold all of the 24,763 net shares received by him at a price of 2859 pence per share.

On 29 March 2011, Tony Zook sold all of the 54,094 net shares received by him at a price of $45.86 per share.

A C N Kemp

Company Secretary

29 March 2011

 

END

 

 

RDSUKONRAAAOUAR